Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Report ID | 155808 |
Drug Identification Number | 02439387 |
Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
Common or Proper name | Ropivacaine Hydrochloride Injection, USP 5 mg/mL Ampoule 10mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | EPIDURAL BLOCK/INFILTRATION EPIDURAL BLOCK/INFILTRATION |
Packaging size | 10mL |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-04-01 |
Actual start date | 2022-04-01 |
Estimated end date | 2022-10-01 |
Actual end date | 2022-09-27 |
Shortage status | Resolved |
Updated date | 2022-10-02 |
Company comments | Fresenius Kabi Canada regrets to advise that due to unforeseen circumstances, we will be extending the backorder on our Ropivacaine Hydrochloride Injection, USP 5 mg/mL Ampoule 10 mL until October 1, 2022. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2022-10-02 | English | Compare |
v11 | 2022-08-29 | French | Compare |
v10 | 2022-08-29 | English | Compare |
v9 | 2022-08-04 | French | Compare |
v8 | 2022-08-04 | English | Compare |
v7 | 2022-07-15 | French | Compare |
v6 | 2022-07-15 | English | Compare |
v5 | 2022-06-27 | French | Compare |
v4 | 2022-06-27 | English | Compare |
v3 | 2022-04-02 | English | Compare |
v2 | 2022-03-01 | French | Compare |
v1 | 2022-03-01 | English | Compare |
Showing 1 to 12 of 12